Parasites, Hosts and Diseases

  • 제46권3호
  • /
  • Pages.191-193
  • /
  • 2008
  • /
  • 2982-5164(pISSN)
  • /
  • 1738-0006(eISSN)
대한기생충학·열대의학회 (The Korea Society for Parasitology and Tropical Medicine)
권호 표지
DOI QR코드

DOI QR Code

Distribution Frequency of Pathogenic Bacteria Isolated from Cutaneus Leishmaniasis Lesions

  • Ziaei, Hengameh (Medical Student, Medical School of Isfahan University of Medical Science) ;
  • Sadeghian, Giti (Department of Dermatology, Skin Disease and Leishmaniasis Research Centre (SDLRC), Isfahan University of Medical Science) ;
  • Hejazi, SH (Department of Parasitology, Medical School of Isfahan University of Medical Science)
  • 발행 : 2008.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Cutaneous leishmaniasis (CL) is a parasitic disease characterized by single or multiple ulcerations. Secondary bacterial infections are one of the complications that can increase the tissue destruction and the resulting scar. To better determine the incidence of real secondary bacterial infections in CL, we designed the current study. This was a cross-sectional study performed in Skin Diseases and Leishmaniasis Research Centre, Isfahan, Iran. A total of 1,255 patients with confirmed CL enrolled in the study. Sterile swaps were achieved for ulcer exudates and scraping was used for non-ulcerated lesions. All samples were transferred to tryptic soy broth medium. After 24 hr of incubation at $37^{\circ}C$ they were transferred to eosin methylene blue agar (EMB) and blood agar. Laboratory tests were used to determine the species of bacteria. Among 1,255 confirmed CL patients, 274 (21.8%) had positive cultures for secondary bacterial infections. The bacteria isolated from the lesions were Staphylococcus aureus in 190 cases (69.3%), coagulase negative Staphylococcus in 63 cases (23.0%), E. coli in 10 cases (3.6%), Proteus sp. in 6 cases (2.2%), and Klebsiella sp. in 5 cases (1.9%). The results show that the overall incidence of secondary bacterial infections in the lesions of CL was 21.8%, considerably high. The incidence of secondary bacterial infections was significantly higher in ulcerated lesions compared with non-ulcerated lesions.

키워드

참고문헌

  1. Desjeux P. Worldwide increasing risk factors for leishmaniasis. Med Microbiol Immunol 2001; 190: 77-79 https://doi.org/10.1007/s004300100085
  2. Addy M, Nandy A. Ten years of kala-azar in west Bengal. Part I. Did postkala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull WHO 1992; 70: 341-346
  3. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891-895 https://doi.org/10.1056/NEJMoa011882
  4. Bryceson AD. Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans Roy Soc Trop Med Hyg 1969; 63: 708-737 https://doi.org/10.1016/0035-9203(69)90116-3
  5. El-Safi SH, Peters W, El-Toam B, El-Kadarow A, Evans DA. Studies on leishmaniasis in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg 1991; 85: 457-464 https://doi.org/10.1016/0035-9203(91)90218-N
  6. El-On J, Sneier R, Elias E. Leishmaniasis major: bacterial contamination of cutaneous lesions in experimental animals. Isr J Med Sci 1992; 28: 847-851
  7. Isaac-Marquez AP, Lezama-Davila CM. Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment. Mem Inst Oswaldo Cruz 2003; 98: 1093-1095 https://doi.org/10.1590/S0074-02762003000800021

피인용 문헌

  1. A Species-Specific Approach to the Use of Non-Antimony Treatments for Cutaneous Leishmaniasis vol.84, pp.1, 2011, https://doi.org/10.4269/ajtmh.2011.10-0437
  2. The relative contribution of co-infection to focal infection risk in children vol.280, pp.1754, 2008, https://doi.org/10.1098/rspb.2012.2813
  3. Bacterial Contamination in Cutaneous Leishmaniasis: Its Effect on the Lesions’ Healing Course vol.60, pp.2, 2015, https://doi.org/10.4103/0019-5154.152560
  4. Cutaneous Manifestations of Human and Murine Leishmaniasis vol.18, pp.6, 2008, https://doi.org/10.3390/ijms18061296
  5. In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major vol.14, pp.7, 2017, https://doi.org/10.3390/ijerph14070777
  6. Coinfection with Leishmania major and Staphylococcus aureus enhances the pathologic responses to both microbes through a pathway involving IL-17A vol.13, pp.5, 2008, https://doi.org/10.1371/journal.pntd.0007247
  7. Curcumin-loaded self-emulsifying drug delivery system (cu-SEDDS): a promising approach for the control of primary pathogen and secondary bacterial infections in cutaneous leishmaniasis vol.103, pp.18, 2019, https://doi.org/10.1007/s00253-019-09990-x